Data on Investigational Orexin-2 Receptor Agonist for Narcolepsy
Alkermes plc will present new data related to ALKS 2680, the company’s novel, investigational orexin-2 receptor (OX2R) agonist in development...
Read moreDetailsAlkermes plc will present new data related to ALKS 2680, the company’s novel, investigational orexin-2 receptor (OX2R) agonist in development...
Read moreDetailsBy Philippa Martyr, The University of Western Australia This article is the first in The Conversation’s six-part series on insomnia,...
Read moreDetailsA new clinical trial is investigating whether a diet meant to reduce inflammation can be beneficial for those with long...
Read moreDetailsOver the past decade, diabetes has reached epidemic proportions, but advances in medical research consistently give people struggling with this...
Read moreDetailsZevra Therapeutics Inc announced that Neil McFarlane has been hired as president and CEO and appointed to the board of...
Read moreDetailsInterest in vitamins, minerals, food supplements, and herbs is growing. Vitaminpedia.org provides nonjudgmental coverage of nutritional options without advocating any particular ones.
© 2022 Vitaminpedia.org